Medical Device Classification in EU

​The European market is the largest industrial and consumer market in the world. Its medical technology market is also one of the biggest, comprising 30% of the world’s market. Understanding medical device classification within the EU is essential for manufacturers aiming to access this lucrative market.

The EU’s regulatory landscape for medical devices underwent a major transformation with the introduction of two new regulations: Regulation (EU) 2017/745 on medical devices (MDR) and Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR). These regulations, which came into force in May 2017, replaced previous directives to address evolving technological advancements, risk classification, and safety concerns.

The MDR replaced Council Directive 90/385/EEC (active implantable medical devices) and Council Directive 93/42/EEC (general medical devices) starting 26 May 2021. Similarly, the IVDR replaced Directive 98/79/EC for in vitro diagnostic medical devices on 26 May 2022. These regulations include transition periods allowing devices compliant with older directives to remain on the market temporarily.

The MDR and IVDR significantly improve upon the previous regulatory framework by introducing stricter requirements for:

• Risk classification – Devices are now reclassified based on a more detailed risk assessment to ensure appropriate regulatory oversight.
• Conformity assessments – Stricter evaluation processes for devices, including increased scrutiny of clinical evidence.
• Post-market surveillance – Enhanced requirements for monitoring devices throughout their lifecycle to identify and mitigate risks promptly.
• Notified body oversight – Strengthened supervision to ensure consistent application of regulatory requirements.
• Eudamed database – The establishment of Eudamed, a centralised database to enhance transparency, traceability, and access to critical information about devices and clinical investigations.

The MDR marks a paradigm shift in how medical devices are regulated in the EU. The stricter classifications mean that many devices previously categorised as low-risk now face more rigorous conformity assessments.

This change impacts on substantive documentation, clinical trials, and higher costs for manufacturers.

Despite these challenges, the Medical Device Regulation (MDR) creates opportunities for manufacturers to demonstrate their commitment to quality and patient safety. Compliance with these regulations enhances credibility and competitiveness, providing a clear advantage in the European and global markets.

1. Increased documentation requirements – The MDR requires detailed technical files, clinical evaluations, and post-market surveillance plans for each device. These requirements can overwhelm small and medium-sized manufacturers.
2. Resource constraints – Many smaller companies lack the expertise or budget to meet the MDR’s stringent requirements, leading to delays or difficulties in achieving certification.
3. ​Continuous monitoring – The MDR emphasises post-market surveillance, requiring manufacturers to invest in robust systems for monitoring, reporting, and addressing device performance issues.

Compliance with the MDR represents an opportunity to excel in a highly competitive market. Manufacturers that meet the MDR’s standards signal their dedication to safety and innovation, building trust with patients, healthcare providers, and regulators.

MDR-compliant devices gain broader market access and enjoy an enhanced reputation globally. This compliance can also attract investors and foster long-term partnerships, ensuring sustained business growth.

Vicki Partridge Pty Ltd specialises in helping manufacturers achieve seamless compliance through tailored consulting services. With a proven track record, the firm offers comprehensive support, including:

• Compliance Consulting;
• Regulatory Approval;
• Medical Device Compliance Training Workshops;
• Pre-Audit Assessments;
• Medical Equipment Consultants;
• Acting as Product Sponsor;
• Clinical Trials Specialist; and
• Medical Device Manufacturers Prosthesis List.​

​As an Australian agent for medical device manufacturers, Vicki Partridge Pty Ltd bridges the gap between regulatory requirements and market success. By partnering with an expert, manufacturers can streamline their compliance journey, reduce risks, and focus on innovation. Vicki can also help manufacturers understand the roles and expectations of notified bodies and proper assessment of technical documentation.

Let Vicki Partridge Pty Ltd guide your business through every step of the regulatory process. From clinical trial guidance to post-market surveillance, Vicki’s tailored services ensure your success in one of the world’s most demanding markets.

For assistance with all your medical device regulatory consulting requirements, Vicki Partridge Pty Ltd can help. Contact Vicki Partridge now.